BCB Bancorp Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BCB Bancorp, Inc. on September 12, 2017, covering events occurring between September 7 and September 12, 2017. The filing primarily reports the execution and closing of an underwritten public offering of common stock.
Key Financial Metrics and Transaction Details
- Shares Issued: 3,265,306 shares of common stock, no par value.
- Offering Price: $12.25 per share.
- Underwriting Discount: $0.6431 per share.
- Net Proceeds: Approximately $37.9 million (excluding the exercise of the underwriters' option).
- Over-Allotment Option: Underwriters were granted a 30-day option to purchase up to an additional 489,796 shares.
- Closing Date: September 12, 2017.
The filing text does not provide specific values for the company's revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transactional report rather than a periodic financial statement.
Material Changes and Agreements
The primary material change is the entry into a definitive underwriting agreement with Keefe, Bruyette & Woods, Inc. as the representative of the underwriters. This agreement facilitated the capital raise described above. Additionally, the Company, its directors, and certain executive officers entered into agreements providing for a 90-day "lock-up" period regarding the sale of specified securities, subject to certain exceptions.
Outlook, Risks, and Management Commentary
The filing incorporates by reference press releases issued on September 7, 8, and 12, 2017, which announced the commencement, pricing, and closing of the offering, respectively. The offering was registered under a shelf registration statement on Form S-3 that became effective on August 10, 2017. The filing notes that the representations, warranties, and covenants in the Underwriting Agreement are not representations of factual information to investors about the Company or its subsidiaries.
Key Facts for Investor Verification
- Verify the final number of shares sold, including whether the 30-day over-allotment option was exercised.
- Confirm the actual net proceeds received after all transaction costs and commissions.
- Review the specific terms of the 90-day lock-up agreement for directors and executive officers.
- Examine the use of proceeds as detailed in the final prospectus supplement dated September 8, 2017.
- Check subsequent filings for any updates on the company's capital structure following this issuance.